Anesthesiology, Pain Medicine · Dallas, TX
NPI
1922205939
Since 2007
Specialty
Anesthesiology, Pain Medicine
Code 207LP2900X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
8210 Walnut Hill Ln, Suite 905
Dallas, TX, 75231
Phone (214) 378-7605
Groups this clinician bills Medicare through
Medicare paid, 2024
$623K
28,733 services
Medicare patients, 2024
387
Average age 75
Drug cost, 2024
$617K
6,481 prescriptions
Company payments, 2025
$1,232
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jemin N Gajipara was code J3473 (injection, hyaluronidase, recombinant, 1 usp unit), 11,250 times for 46 patients. In total Jemin N Gajipara billed 28,733 services in 68 codes, and Medicare paid $623K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-04-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3473 Injection, hyaluronidase, recombinant, 1 usp unit | Office | 11,250 | 46 | $0.29 | $3,207 |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 10,587 | 82 | $0.10 | $1,073 |
| 99214 Office E&M - Established | Office | 1,612 | 342 | $91.36 | $147K |
| 80307 Drug Tests | Office | 1,374 | 332 | $60.09 | $83K |
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 1,223 | 310 | $112.14 | $137K |
| G0396 Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | Office | 489 | 290 | $25.83 | $13K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 485 | 72 | $0.77 | $373 |
| 99204 Office E&M - New | Office | 114 | 114 | $122.57 | $14K |
| 99213 Office E&M - Established | Office | 99 | 76 | $62.37 | $6,175 |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 91 | 91 | $153.46 | $14K |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 76 | 25 | $0.41 | $30.98 |
| G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 60 | 36 | $158.17 | $9,490 |
| 64450 Musculoskeletal | Office | 52 | 37 | $54.53 | $2,836 |
| 62323 Nerve Block Injection - Back | Facility | 49 | 47 | $76.71 | $3,759 |
| 62264 Musculoskeletal | Office | 47 | 46 | $343.87 | $16K |
By year: 2022 $603K for 6,316 services; 2023 $631K for 7,944 services; 2024 $623K for 28,733 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 1,374 | 332 | $60.09 | $83K |
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 1,223 | 310 | $112.14 | $137K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 91 | 91 | $153.46 | $14K |
| G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 60 | 36 | $158.17 | $9,490 |
Medicare prescription drug claims, 2024
In 2024, the drug Jemin N Gajipara prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 1,609 prescriptions and refills. In total Jemin N Gajipara wrote 6,481 Medicare prescriptions that cost $617K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 1,609 | 1,609 | 274 | $68K |
| Tramadol Hcl Er Tramadol Hcl | 423 | 423 | 93 | $26K |
| Buprenorphine Hcl Generic | 385 | 389 | 67 | $9,884 |
| Gabapentin Generic | 333 | 548 | 131 | $4,911 |
| Morphine Sulfate Er Morphine Sulfate | 323 | 323 | 51 | $10K |
| Tramadol Hcl Generic | 323 | 324 | 113 | $3,326 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 312 | 312 | 106 | $8,261 |
| Baclofen Generic | 262 | 403 | 120 | $4,528 |
| Tizanidine Hcl Generic | 246 | 389 | 115 | $3,113 |
| Oxycodone Hcl Generic | 175 | 175 | 56 | $3,488 |
| Buprenorphine Generic | 174 | 174 | 64 | $33K |
| Pregabalin Generic | 150 | 268 | 52 | $3,415 |
| Morphine Sulfate Generic | 141 | 141 | 33 | $4,148 |
| Nucynta Er Tapentadol Hcl | 121 | 121 | 14 | $134K |
| Fentanyl Generic | 111 | 111 | 17 | $11K |
Brand drugs: 502 claims; generic drugs: 5,979 claims; opioid claims: 4,159.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jemin N Gajipara $1,232 ($1,232 in general payments such as food, travel and fees) from 15 companies. The largest payer was TerSera Therapeutics LLC with $213.
| Company | Payments | Amount |
|---|---|---|
| TerSera Therapeutics LLC | 10 | $213 |
| Collegium Pharmaceutical, Inc. COLL | 13 | $199 |
| Curonix LLC | 4 | $154 |
| Protega Pharmaceutials Inc | 6 | $138 |
| BIOTRONIK NRO, Inc. | 1 | $104 |
| Vertex Pharmaceuticals Incorporated VRTX | 4 | $90.14 |
| Valinor Pharma, LLC | 4 | $82.21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $58.75 |
| Boston Scientific Corporation BSX | 2 | $41.27 |
| Medtronic, Inc. MDT | 2 | $40.19 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.